Celsius Holdings (CELH) PT Lowered to $37 at Stifel

Stifel analyst Mark Astrachan lowered the price target on Celsius Holdings (NASDAQ: CELH) to $37.00 (from $45.00) while maintaining a Buy rating.

The analyst commented, “we now model 1Q25E and 2Q25E sales growth of -8% (consensus +4%) and +2% (consensus +5), respectively, with meaningfully stronger growth anticipated in 2H25 reflecting more favorable prior year comparisons, including Pepsi-related destocking in 3Q24."

Also, "Our sales build-up is calculated as the output of sales velocities and distribution points, where we maintain the current 2-year CAGR for each. From a stock standpoint, we continue to see CELH shares as range-bound pending improvement in sales and market share in U.S. scanner data.”

You May Also Be Interested In

• Outset Medical Inc. (OM) PT Raised to $15 at Stifel
• Clearlake Said to be Near Deal to Buy Dun & Bradstreet (DNB) for $9/Sh - Bloomberg
• Darden Restaurants (DRI) Shows 'Evidence of Resilience'; PT Raised to $220 at KeyBanc